VITA 34 AG Profile Avatar - Palmy Investing

VITA 34 AG

VITA 34 AG engages in the collection, processing, and storage of stem cells from umbilical cord blood and tissue in Germany, Spain, and internationally. It also develops cell therapeutic procedures; cell and gene therapies; cryopreservation of endogenous…

Medical - Care Facilities
DE, Leipzig [HQ]

Cash Flow Statements

15 Records · Starting from 2009
In Million EUR. Margins, Growth Rates In %
Metric 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Operating Activities
Operating Cash Flow (OCF)
1.00 1.00 - - 2.00 1.00 1.00 2.00 2.00 1.00 4.00 6.00 3.00 2.00 -4.00 9.00
Operating Cash (Net)
1.00 1.00 - - 2.00 1.00 1.00 2.00 2.00 1.00 4.00 6.00 3.00 2.00 -4.00 9.00
Accounts Receivable
- - - - - - - - - - -1.00 2.00 - - - - 1.00 - - - - 1.00 -1.00 -7.00
Accounts Payable
- - - - - - - - - - - - - - - - - - - - - - - - -1.00 1.00 - -
Working Capital
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Investing Activities
Used Cash (Net)
-1.00 -4.00 - - - - - - - - -4.00 - - -13.00 - - -1.00 - - 24.00 -5.00 -4.00
Capital Expenditure
- - - - -1.00 - - - - - - -3.00 - - - - - - - - - - -2.00 -6.00 -4.00
Purchases of Investments
-1.00 -1.00 - - - - - - - - - - - - - - - - - - - - - - - - - -
Sale/Maturity of Investment
- - 2.00 1.00 - - - - - - - - - - - - 2.00 - - - - - - - - - -
Property, Plant, Equipment (P&PE)
- - - - -1.00 - - - - - - -3.00 - - - - - - - - - - -2.00 -6.00 -4.00
Acquisitions (Net)
- - -4.00 - - - - - - - - -1.00 - - -12.00 - - - - - - 27.00 2.00 - -
Other Investing Activities
- - - - - - - - - - - - - - - - - - - - - - - - - - -1.00 - -
Financing Activities
Used Cash (Net)
- - - - - - - - -1.00 - - - - - - -12.00 -2.00 -2.00 -2.00 -4.00 -6.00 -3.00
Debt Repayment
- - - - - - -1.00 -1.00 - - - - - - - - -1.00 -1.00 -1.00 -2.00 -6.00 -7.00
Dividends Paid
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Common Stock
- - - - - - - - - - - - - - - - - - - - - - - - 1 - - - -
Other Financing Activities
- - - - - - - - -1.00 - - - - - - 7.00 - - - - - - -1.00 - - - -
Cash Balances
Begin of Period
6.00 6.00 3.00 3.00 3.00 2.00 3.00 2.00 2.00 4.00 6.00 9.00 10.00 33.00 16.00
End of Period
6.00 3.00 3.00 3.00 2.00 3.00 2.00 2.00 4.00 6.00 9.00 10.00 33.00 16.00 17.00
Change
- - -2.00 - - - - - - - - -1.00 - - 1.00 2.00 2.00 1.00 22.00 -17.00 1.00
Non-Cash Balances
Depreciation and Amortization
- - - - - - 1.00 1.00 1.00 2.00 1.00 1.00 2.00 2.00 2.00 3.00 8.00 8.00
Stock Based Compensation
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Other
- - - - - - - - - - - - -3.00 - - - - - - - - -1.00 -1.00 14.00 24.00
Highlighted metrics
Free Cash Flow (FCF)
- - - - -1.00 1.00 1.00 - - -1.00 1.00 - - 3.00 5.00 3.00 - - -10.00 5.00
Cash Conversion Cycle (CCC)
-19.00 -15.00 -3.00 36.00 36.00 78.00 53.00 62.00 74.00 40.00 11.00 24.00 119.00 75.00 40.00
Invested Capital
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Other Operating Inflows/Outflows
End of V3V.DE's Analysis
CIK: - CUSIP: D9506F102 ISIN: DE000A0BL849 LEI: - UEI: -
Secondary Listings
V3V.DE has no secondary listings inside our databases.